The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study.

The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study.

<h4>Background</h4>Pharmacological treatment with lipid-lowering and antihypertensive drugs has been proposed as a strategy to improve excess cardiovascular (CV) risk among obese individuals. The present study aimed to assess whether the CV polypill (Sincronium®) could be an effective st...

Full description

Bibliographic Details
Main Authors: José Alejandro Chávez Fernández, Marcelo Ramírez Mendoza, Hermelinda Kassck Ipinaa, Luís Antonio Sánchez Ángeles, Antonio González Chávez, Galileo Escobedo, Lucía Angélica Méndez-García
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0290544

Internet

https://doi.org/10.1371/journal.pone.0290544

Similar Items